119 related articles for article (PubMed ID: 38070775)
1. Stability of Rapidly Crystallizing Sulfonamides Glasses by Fast Scanning Calorimetry: Crystallization Kinetics and Glass-Forming Ability.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
J Pharm Sci; 2024 May; 113(5):1257-1264. PubMed ID: 38070775
[TBL] [Abstract][Full Text] [Related]
2. Crystallization kinetics and glass-forming ability of rapidly crystallizing drugs studied by Fast Scanning Calorimetry.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
Int J Pharm; 2021 Apr; 599():120427. PubMed ID: 33662469
[TBL] [Abstract][Full Text] [Related]
3. Kinetic stability of amorphous dipyridamole: A fast scanning calorimetry investigation.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
Int J Pharm; 2020 Jan; 574():118890. PubMed ID: 31809857
[TBL] [Abstract][Full Text] [Related]
4. Kinetic Stability and Glass-Forming Ability of Thermally Labile Quinolone Antibiotics.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
Mol Pharm; 2023 Jun; 20(6):3202-3209. PubMed ID: 37133972
[TBL] [Abstract][Full Text] [Related]
5. Vitrification of two active pharmaceutical ingredients by fast scanning calorimetry: From structural relaxation to nucleation phenomena.
Monnier X; Viel Q; Schammé B; Petit S; Delbreilh L; Dupray V; Coquerel G; Dargent E
Int J Pharm; 2018 Jan; 536(1):426-433. PubMed ID: 29225097
[TBL] [Abstract][Full Text] [Related]
6. Kinetic stability of amorphous solid dispersions with high content of the drug: A fast scanning calorimetry investigation.
Lapuk SE; Zubaidullina LS; Ziganshin MA; Mukhametzyanov TA; Schick C; Gerasimov AV
Int J Pharm; 2019 May; 562():113-123. PubMed ID: 30902705
[TBL] [Abstract][Full Text] [Related]
7. Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
Kawakami K; Usui T; Hattori M
J Pharm Sci; 2012 Sep; 101(9):3239-48. PubMed ID: 22531946
[TBL] [Abstract][Full Text] [Related]
8. Origin of two modes of non-isothermal crystallization of glasses produced by milling.
Chattoraj S; Bhugra C; Telang C; Zhong L; Wang Z; Sun CC
Pharm Res; 2012 Apr; 29(4):1020-32. PubMed ID: 22173781
[TBL] [Abstract][Full Text] [Related]
9. Isothermal Crystallization Monitoring and Time-Temperature-Transformation of Amorphous GDC-0276: Differential Scanning Calorimetric and Rheological Measurements.
Cheng S; Chakravarty P; Nagapudi K; McKenna GB
Mol Pharm; 2021 Jan; 18(1):158-173. PubMed ID: 33259220
[TBL] [Abstract][Full Text] [Related]
10. Phase transformations undergone by Triton X-100 probed by differential scanning calorimetry and dielectric relaxation spectroscopy.
Merino EG; Rodrigues C; Viciosa MT; Melo C; Sotomayor J; Dionísio M; Correia NT
J Phys Chem B; 2011 Nov; 115(43):12336-47. PubMed ID: 21928821
[TBL] [Abstract][Full Text] [Related]
11. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
Karmwar P; Boetker JP; Graeser KA; Strachan CJ; Rantanen J; Rades T
Eur J Pharm Sci; 2011 Oct; 44(3):341-50. PubMed ID: 21884789
[TBL] [Abstract][Full Text] [Related]
12. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
[TBL] [Abstract][Full Text] [Related]
13. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine.
Baghel S; Cathcart H; Redington W; O'Reilly NJ
Eur J Pharm Biopharm; 2016 Jul; 104():59-71. PubMed ID: 27108783
[TBL] [Abstract][Full Text] [Related]
15. Glass Forming Ability of Amorphous Drugs Investigated by Continuous Cooling and Isothermal Transformation.
Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2016 Sep; 13(9):3318-25. PubMed ID: 27529364
[TBL] [Abstract][Full Text] [Related]
16. Fragility and Tendency to Crystallization for Structurally Related Compounds.
Grzybowska K; Wojnarowska Z; Grzybowski A; Paluch M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542174
[TBL] [Abstract][Full Text] [Related]
17. Dipolar Reorientations in Amorphous Nimesulide: A TSDC and DSC Study.
Moura Ramos JJ; Diogo HP
Curr Drug Deliv; 2017; 14(1):91-98. PubMed ID: 27160253
[TBL] [Abstract][Full Text] [Related]
18. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
19. What We Need to Know about Solid-State Isothermal Crystallization of Organic Molecules from the Amorphous State below the Glass Transition Temperature.
Newman A; Zografi G
Mol Pharm; 2020 Jun; 17(6):1761-1777. PubMed ID: 32275832
[TBL] [Abstract][Full Text] [Related]
20. Application of advanced thermal analysis for characterization of crystalline and amorphous phases of carvedilol.
Skotnicki M; Czerniecka-Kubicka A; Neilsen G; Woodfield BF; Pyda M
J Pharm Biomed Anal; 2022 Aug; 217():114822. PubMed ID: 35550491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
